TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 16646004

Group type: EXPERIMENTAL
Intervention: Etanercept
Number of subjects: 180

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 180
Study: 15508673

Group type: EXPERIMENTAL
Intervention: 40 IU of vasopressin
Number of subjects: 1219

Group type: EXPERIMENTAL
Intervention: Vasopressin followed by epinephrine
Number of subjects: 1219

Group type: COMPARATOR
Intervention: 1 mg of epinephrine
Number of subjects: 1219

Group type: EXPERIMENTAL
Intervention: Combinations of vasopressin and epinephrine
Number of subjects: 1219

Group type: EXPERIMENTAL
Intervention: Vasopressin
Number of subjects: 1219
Study: 11381289

Group type: EXPERIMENTAL
Intervention: Ramipril (ACE inhibitor)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vitamin E
Number of subjects: 0
Study: 9231814

Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 5198

Group type: COMPARATOR
Intervention: Active drug controls
Number of subjects: 5198

Group type: EXPERIMENTAL
Intervention: Nifedipine monotherapy
Number of subjects: 5198

Group type: EXPERIMENTAL
Intervention: Nifedipine in combination with another drug
Number of subjects: 5198

Group type: EXPERIMENTAL
Intervention: Nifedipine monotherapy vs combined therapy
Number of subjects: 5198
Study: 8215633

Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) 0.14 mg/kg/day
Number of subjects: 14

Group type: COMPARATOR
Intervention: Standard nutritional therapy (STD) providing approximately 50 kcal/kg/day and 2 g of protein/kg/day
Number of subjects: 14
Study: 2882180

Group type: EXPERIMENTAL
Intervention: 13-cis-retinoic acid
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Sideroblastic anaemia patients
Number of subjects: 70
Study: 29979912

Group type: EXPERIMENTAL
Intervention: Individualized multimodal treatment including manual therapy, patient education, stretching, resistance training, and neurodynamic interventions.
Number of subjects: 0
Study: 30016335

Group type: EXPERIMENTAL
Intervention: peginterferon alfa-2a
Number of subjects: 701
Study: 26980460

Group type: EXPERIMENTAL
Intervention: Bitopertin 5 mg/day
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Bitopertin 10 mg/day
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Bitopertin 20 mg/day
Number of subjects: 161

Group type: COMPARATOR
Intervention: Control (existing antipsychotics)
Number of subjects: 161
Study: 25651610

Group type: EXPERIMENTAL
Intervention: 250 g/day banana for 12 weeks
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 500 g/day banana for 12 weeks
Number of subjects: 45
Study: 22522403

Group type: EXPERIMENTAL
Intervention: Telmisartan
Number of subjects: 378

Group type: COMPARATOR
Intervention: Amlodipine
Number of subjects: 378
Study: 20712869

Group type: EXPERIMENTAL
Intervention: Prolonged release melatonin (PRM) for 3 weeks
Number of subjects: 791

Group type: EXPERIMENTAL
Intervention: Prolonged release melatonin (PRM) for 26 weeks
Number of subjects: 791

Group type: COMPARATOR
Intervention: Placebo for 2 weeks followed by placebo for 26 weeks
Number of subjects: 791

Group type: COMPARATOR
Intervention: Placebo for 3 weeks
Number of subjects: 791
Study: 18674977

Group type: EXPERIMENTAL
Intervention: 8-week stretching program
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (maintained activity level for 8 weeks)
Number of subjects: 40
Study: 15986032

Group type: EXPERIMENTAL
Intervention: Nurse-managed intervention including trial exit interview, trial feedback information leaflet, and telephone follow-up
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Nurse-managed intervention
Number of subjects: 117

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 117
Study: 12027266

Group type: EXPERIMENTAL
Intervention: In-person survey regarding HBV knowledge, beliefs, and practices
Number of subjects: 320
Study: 10333377

Group type: EXPERIMENTAL
Intervention: Short-term tryptophan (TRP) depletion
Number of subjects: 18

Group type: COMPARATOR
Intervention: Healthy control subjects
Number of subjects: 18
Study: 7851580

Group type: EXPERIMENTAL
Intervention: Low-dose estrogen oral contraceptives (OC)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control (non-users)
Number of subjects: 49
Study: 1778190

Group type: EXPERIMENTAL
Intervention: Transdermal glyceryl trinitrate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intermittent therapy with transdermal glyceryl trinitrate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Matching placebo transdermal patches
Number of subjects: 0
Study: 6247910

Group type: EXPERIMENTAL
Intervention: Prophylactic granulocyte transfusions and oral nonabsorbable antibiotics (group 1)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Oral nonabsorbable antibiotics alone (group 2)
Number of subjects: 38
Study: 31809198

Group type: EXPERIMENTAL
Intervention: Sustained isometric maximal voluntary contractions (IMVCs) with blood flow occlusion via pneumatic cuff
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sustained isometric maximal voluntary contractions (IMVCs) without blood flow occlusion
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Sustained isometric maximal voluntary contractions (IMVCs) with blood flow occlusion
Number of subjects: 12
Study: 31127163

Group type: EXPERIMENTAL
Intervention: Moderate-to-high intensity resistance circuit training for 12 weeks
Number of subjects: 45

Group type: COMPARATOR
Intervention: No exercise intervention (Control group)
Number of subjects: 45
Study: 28320331

Group type: EXPERIMENTAL
Intervention: FIT-HIP intervention (multi-component cognitive behavioural intervention)
Number of subjects: 165

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 165
Study: 26073456

Group type: EXPERIMENTAL
Intervention: Remifentanil patient-controlled analgesia (RPCA)
Number of subjects: 290

Group type: COMPARATOR
Intervention: Epidural analgesia (EA)
Number of subjects: 290
Study: 23677858

Group type: EXPERIMENTAL
Intervention: itraconazole (100 mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: rifampicin (450 mg/day for 6 days)
Number of subjects: 10

Group type: COMPARATOR
Intervention: grapefruit juice (300 mL)
Number of subjects: 10

Group type: COMPARATOR
Intervention: control (water)
Number of subjects: 10
Study: 22590901

Group type: EXPERIMENTAL
Intervention: Day 1 zygote transfer
Number of subjects: 254

Group type: COMPARATOR
Intervention: Day 3 embryo transfer
Number of subjects: 254
Study: 19118875

Group type: EXPERIMENTAL
Intervention: Testosterone gel therapy for 3 months
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 17006963

Group type: EXPERIMENTAL
Intervention: Patient health valuations
Number of subjects: 0

Group type: COMPARATOR
Intervention: General population health valuations
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Treatment for moderate varicose veins
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Elicitation technique
Number of subjects: 0
Study: 15233777

Group type: EXPERIMENTAL
Intervention: Probing depth measurements
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Repeated measurement
Number of subjects: 15
Study: 11326395

Group type: EXPERIMENTAL
Intervention: Think First for Kids (TFFK) intervention program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 9392555

Group type: EXPERIMENTAL
Intervention: Physical simulation followed by port filming
Number of subjects: 75

Group type: COMPARATOR
Intervention: No physical simulation, only port filming
Number of subjects: 75
Study: 7910323

Group type: EXPERIMENTAL
Intervention: Tamoxifen (20 mg/day)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 111
Study: 3361980

Group type: EXPERIMENTAL
Intervention: Beta 2-mimetics
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31522784

Group type: EXPERIMENTAL
Intervention: Teduglutide 0.05 mg/kg/day for 24 and 36 months
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Histology results for 7 patients
Number of subjects: 73
Study: 30318065

Group type: EXPERIMENTAL
Intervention: Evolocumab
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study: 28355708

Group type: EXPERIMENTAL
Intervention: Intravenous injection of Ginkgo biloba (Ginaton) 70 mg once a day for 2 weeks
Number of subjects: 84

Group type: COMPARATOR
Intervention: Routine treatments of hyperbaric oxygen, cure cerebral edema, and promote brain cell metabolism
Number of subjects: 84
Study: 26264371

Group type: EXPERIMENTAL
Intervention: Moderate/severe pulmonary hypertension (mPAP ≥35 mm Hg)
Number of subjects: 2180

Group type: EXPERIMENTAL
Intervention: Mild pulmonary hypertension (mPAP <35 mm Hg)
Number of subjects: 2180

Group type: EXPERIMENTAL
Intervention: None pulmonary hypertension (mPAP <35 mm Hg)
Number of subjects: 2180

Group type: EXPERIMENTAL
Intervention: Clinical factors (oxygen-dependent lung disease, inability to perform a 6 min walk, impaired renal function, lower aortic valve mean gradient)
Number of subjects: 2180

Group type: EXPERIMENTAL
Intervention: Risk score including clinical factors
Number of subjects: 2180
Study: 23756273

Group type: EXPERIMENTAL
Intervention: Early staple removal (postoperative day 3)
Number of subjects: 295

Group type: COMPARATOR
Intervention: Delayed staple removal (between postoperative day 7 and day 10)
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: Early staple removal
Number of subjects: 295

Group type: COMPARATOR
Intervention: Delayed staple removal
Number of subjects: 295
Study: 20415638

Group type: EXPERIMENTAL
Intervention: rhGH 1.5 mg scqd + ART for 48 weeks (Arm A)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: rhGH 3.0 mg scqd + ART for 24 weeks (Arm B)
Number of subjects: 60

Group type: COMPARATOR
Intervention: ART alone for 24 weeks then rhGH 3.0 mg scqd for 24 weeks (Arm B)
Number of subjects: 60
Study: 18590757

Group type: EXPERIMENTAL
Intervention: Heart-rate feedback with educational program (EG)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Heart-rate feedback without educational program (NEG)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 210
Study: 16761010

Group type: EXPERIMENTAL
Intervention: Less rigid glucose management
Number of subjects: 22

Group type: COMPARATOR
Intervention: Rigid glucose management
Number of subjects: 22
Study: 14674814

Group type: EXPERIMENTAL
Intervention: High-power men attentive to subordinate weaknesses in a masculine domain
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-power men attentive to subordinate strengths in a masculine domain
Number of subjects: 0
Study: 10983669

Group type: EXPERIMENTAL
Intervention: Primary percutaneous transluminal coronary angioplasty (PTCA)
Number of subjects: 164

Group type: COMPARATOR
Intervention: Thrombolytic therapy
Number of subjects: 164
Study: 9026181

Group type: EXPERIMENTAL
Intervention: Nitroglycerin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Beta-blockers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Calcium antagonists
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of drugs
Number of subjects: 0
Study: 1335361

Group type: EXPERIMENTAL
Intervention: 2 mg sumatriptan
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 4 mg sumatriptan
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 6367368

Group type: EXPERIMENTAL
Intervention: Adrenergic beta‐receptor blockade with oxprenolol
Number of subjects: 22

Group type: COMPARATOR
Intervention: Untreated essential hypertension of the low renin type
Number of subjects: 22
Study: 31734568

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral System of Psychotherapy (CBASP) for 48 weeks
Number of subjects: 237

Group type: COMPARATOR
Intervention: Supportive psychotherapy (SP) for 48 weeks
Number of subjects: 237
Study: 30221438

Group type: EXPERIMENTAL
Intervention: Dog-assisted therapy
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control group (no dog-assisted therapy)
Number of subjects: 31
Study: 28917154

Group type: EXPERIMENTAL
Intervention: Cognitive training intervention (12-week duration)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Treatment-as-usual control group
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Baseline assessment (n-back task during fMRI)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Post-stress rehabilitation
Number of subjects: 55
Study: 25721184

Group type: EXPERIMENTAL
Intervention: Family-based interpersonal psychotherapy (FB-IPT)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Child-centered therapy (CCT)
Number of subjects: 42
Study: 23968458

Group type: EXPERIMENTAL
Intervention: Faustlos (violence prevention program)
Number of subjects: 5300

Group type: EXPERIMENTAL
Intervention: Early Steps (psychoanalytically based intervention)
Number of subjects: 5300
Study: 21376917

Group type: EXPERIMENTAL
Intervention: Pay-As-You-Drive insurance fee
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 19778661

Group type: EXPERIMENTAL
Intervention: Risk estimation systems
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: New risk factors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multiple risk estimation approach
Number of subjects: 0
Study: 17727813

Group type: EXPERIMENTAL
Intervention: Detailed sensory description of the cold-pressor task (cold-pressor arm immersion in 10 degrees C water) with imagery-based distraction intervention.
Number of subjects: 78

Group type: COMPARATOR
Intervention: Detailed sensory description of the cold-pressor task (cold-pressor arm immersion in 10 degrees C water) without distraction.
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Control instructions lacking sensory information with imagery-based distraction intervention.
Number of subjects: 78

Group type: COMPARATOR
Intervention: Control instructions lacking sensory information without distraction.
Number of subjects: 78
Study: 15592552

Group type: EXPERIMENTAL
Intervention: Partial caries removal followed by lining with black copper cement (BCC) and restoration with glass ionomer cement (GIC) (PCR:BCC)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Partial caries removal and restoration with GIC alone (PCR:GIC)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Complete caries removal and conventional restoration (CR)
Number of subjects: 44
Study: 11451599

Group type: EXPERIMENTAL
Intervention: Sucralfate Cream
Number of subjects: 85

Group type: COMPARATOR
Intervention: Other topical antimicrobial agents
Number of subjects: 85

Group type: COMPARATOR
Intervention: Placebo ointment
Number of subjects: 85
Study: 9751681

Group type: EXPERIMENTAL
Intervention: Single-chamber atrial pacing (110 patients)
Number of subjects: 225

Group type: COMPARATOR
Intervention: Single-chamber ventricular pacing (115 patients)
Number of subjects: 225
Study: 8141172

Group type: EXPERIMENTAL
Intervention: Severe sodium restriction (20 mmol Na/d)
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Moderate sodium restriction (85 mmol Na/d)
Number of subjects: 163

Group type: COMPARATOR
Intervention: High sodium diet (300 mmol Na/d)
Number of subjects: 163

Group type: COMPARATOR
Intervention: Normal sodium diet (200 mmol Na/d)
Number of subjects: 163
Study: 3061311

Group type: EXPERIMENTAL
Intervention: Bambuterol 0.185 mg/kg
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Bambuterol 0.270 mg/kg
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Bambuterol 0.400 mg/kg
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Bambuterol (all doses)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Objective measurements of tremor
Number of subjects: 22
Study: 30160543

Group type: EXPERIMENTAL
Intervention: Palm Olein (POL)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Cocoa Butter (CB)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Extra Virgin Olive Oil (EVOO)
Number of subjects: 67
Study: 28649780

Group type: EXPERIMENTAL
Intervention: Oral TXA 250 mg twice daily
Number of subjects: 100

Group type: COMPARATOR
Intervention: Intraderma microinjections of TXA 4 mg/mL every 4 weeks
Number of subjects: 100
Study: 25958319

Group type: EXPERIMENTAL
Intervention: IV doxorubicin plus intraperitoneal (IP) paclitaxel and IV or IP cisplatin (TAP regimen)
Number of subjects: 21
Study: 23074995

Group type: EXPERIMENTAL
Intervention: Post-operative cervical collar usage (n = 17)
Number of subjects: 33

Group type: COMPARATOR
Intervention: No post-operative cervical collar usage (n = 16)
Number of subjects: 33
Study: 21292895

Group type: EXPERIMENTAL
Intervention: Oral miltefosine (2.5 mg/kg/day for 28 days)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Parenteral antimony (15-20 mg/Sb/kg/day for 20 days)
Number of subjects: 90
Study: 16527863

Group type: EXPERIMENTAL
Intervention: Pedalling frequency at 60 r.p.m.
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Pedalling frequency at 100 r.p.m.
Number of subjects: 11

Group type: COMPARATOR
Intervention: Cross-country runners (END) at both pedal frequencies.
Number of subjects: 11

Group type: COMPARATOR
Intervention: Sprinters (SPR) at both pedal frequencies.
Number of subjects: 11
Study: 14503832

Group type: EXPERIMENTAL
Intervention: ISO standards
Number of subjects: 30

Group type: COMPARATOR
Intervention: Root-dipping technique
Number of subjects: 30
Study: 10965516

Group type: EXPERIMENTAL
Intervention: Yogurt treatment (2 cups, 454 g/day) for three months
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control (no yogurt consumption for three months)
Number of subjects: 25
Study: 9069134

Group type: EXPERIMENTAL
Intervention: Laparoscopic appendectomy
Number of subjects: 50

Group type: COMPARATOR
Intervention: Open appendectomy
Number of subjects: 50
Study: 8450576

Group type: EXPERIMENTAL
Intervention: Pharmacotherapies for cocaine abuse (specifics not provided)
Number of subjects: 0
Study: 2980616

Group type: EXPERIMENTAL
Intervention: Bypass surgery
Number of subjects: 1377

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 1377
Study: 30439971

Group type: EXPERIMENTAL
Intervention: Person-centered and integrated-care service (Embrace)
Number of subjects: 11
Study: 26928838

Group type: EXPERIMENTAL
Intervention: Oral Cholera Vaccine (OCV)
Number of subjects: 388

Group type: COMPARATOR
Intervention: Control (Unvaccinated)
Number of subjects: 388
Study: 24071820

Group type: EXPERIMENTAL
Intervention: Intrauterine lidocaine
Number of subjects: 120

Group type: COMPARATOR
Intervention: Paracervical block
Number of subjects: 120
Study: 22323710

Group type: EXPERIMENTAL
Intervention: Weightlessness condition during parabolic flight
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ground trials
Number of subjects: 0
Study: 20361924

Group type: COMPARATOR
Intervention: Almond skin polyphenols
Number of subjects: 0
Study: 18415764

Group type: EXPERIMENTAL
Intervention: Three disease-modifying anti-rheumatic drugs (DMARDs) and low-dose prednisolone (COMBI)
Number of subjects: 182

Group type: COMPARATOR
Intervention: Single DMARD with or without low-dose prednisolone (SINGLE)
Number of subjects: 182
Study: 15660084

Group type: EXPERIMENTAL
Intervention: Chlorhexidine rinse on the day of surgery only
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Chlorhexidine rinse on the day of surgery and several days after
Number of subjects: 7
Study: 12028323

Group type: EXPERIMENTAL
Intervention: Frovatriptan doses of 2.5 to 40 mg
Number of subjects: 1453

Group type: COMPARATOR
Intervention: Frovatriptan doses of 0.5 mg and 1 mg
Number of subjects: 1453

Group type: EXPERIMENTAL
Intervention: Frovatriptan dose of 2.5 mg
Number of subjects: 1453

Group type: EXPERIMENTAL
Intervention: Frovatriptan doses above 2.5 mg
Number of subjects: 1453

Group type: EXPERIMENTAL
Intervention: Frovatriptan doses of 10 mg and above
Number of subjects: 1453
Study: 10726234

Group type: EXPERIMENTAL
Intervention: Zolpidem 10 mg for 1 week
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Zolpidem 10 mg for 3 weeks
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 8784216

Group type: EXPERIMENTAL
Intervention: Gabapentin (GBP)
Number of subjects: 0
Study: 2264710

Group type: EXPERIMENTAL
Intervention: Bepridil (300 to 500 mg/day)
Number of subjects: 227

Group type: COMPARATOR
Intervention: Diltiazem (180 to 300 mg/day)
Number of subjects: 227
Study: 442947

Group type: EXPERIMENTAL
Intervention: Suxamethonium
Number of subjects: 28
Study: 30767047

Group type: EXPERIMENTAL
Intervention: Streptococcus salivarius 24SMB and Streptococcus oralis 89a oral spray
Number of subjects: 82

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82
Study: 27893222

Group type: EXPERIMENTAL
Intervention: Facial expressions not previously theorized to signal any emotion
Number of subjects: 1068

Group type: EXPERIMENTAL
Intervention: Three different facial expressions
Number of subjects: 1068

Group type: EXPERIMENTAL
Intervention: Prototypical sad expression
Number of subjects: 1068

Group type: EXPERIMENTAL
Intervention: Prototypical fear expression
Number of subjects: 1068

Group type: EXPERIMENTAL
Intervention: Facial expression labeled with a made-up word (tolen)
Number of subjects: 1068

Group type: EXPERIMENTAL
Intervention: Context focused on demonstrating a process of elimination
Number of subjects: 1068

Group type: EXPERIMENTAL
Intervention: Commonly used method with 4 target expressions
Number of subjects: 1068
Study: 26674992

Group type: EXPERIMENTAL
Intervention: faith-based lifestyle intervention
Number of subjects: 373

Group type: COMPARATOR
Intervention: health education control
Number of subjects: 373
Study: 23524367

Group type: EXPERIMENTAL
Intervention: 20 seconds stretching
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 60 seconds stretching
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 180 seconds stretching
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 300 seconds stretching
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: All stretching durations
Number of subjects: 24
Study: 21293304

Group type: EXPERIMENTAL
Intervention: Caffeine (6 mg · kg(‐1))
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Caffeine
Number of subjects: 14
Study: 19646174

Group type: EXPERIMENTAL
Intervention: Burnout intervention programme (details on dosage and duration not available)
Number of subjects: 18
Study: 17825695

Group type: EXPERIMENTAL
Intervention: Intravenous tramadol 100 mg in 100-mL saline
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo (100-mL saline)
Number of subjects: 34
Study: 14975049

Group type: EXPERIMENTAL
Intervention: Remifentanil (9 microgram/kg per hour)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Fentanyl (1.5 microgram/kg per hour)
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Remifentanil
Number of subjects: 152

Group type: COMPARATOR
Intervention: Fentanyl
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Remifentanil and Fentanyl
Number of subjects: 152